Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1953 1
1960 1
1964 1
1968 3
1969 2
1970 2
1972 2
1973 4
1974 2
1975 1
1976 2
1977 2
1978 4
1979 1
1980 2
1981 1
1982 2
1983 1
1984 5
1985 2
1987 3
1988 2
1989 3
1990 2
1991 7
1992 3
1993 6
1994 14
1995 11
1996 18
1997 16
1998 22
1999 20
2000 18
2001 11
2002 32
2003 24
2004 41
2005 27
2006 22
2007 33
2008 26
2009 37
2010 33
2011 40
2012 36
2013 38
2014 49
2015 41
2016 52
2017 46
2018 46
2019 31
2020 43
2021 47
2022 49
2023 39
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

945 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis, prognosis, and treatment of leukodystrophies.
van der Knaap MS, Schiffmann R, Mochel F, Wolf NI. van der Knaap MS, et al. Lancet Neurol. 2019 Oct;18(10):962-972. doi: 10.1016/S1474-4422(19)30143-7. Epub 2019 Jul 12. Lancet Neurol. 2019. PMID: 31307818 Review.
Technological advance in molecular techniques and improved insight into the pathophysiology of individual leukodystrophies have led to therapeutic developments, including drug design and gene therapy. Despite this progress, therapies are only beneficial early …
Technological advance in molecular techniques and improved insight into the pathophysiology of individual leukodystrophies have led to th …
X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies.
Turk BR, Theda C, Fatemi A, Moser AB. Turk BR, et al. Int J Dev Neurosci. 2020 Feb;80(1):52-72. doi: 10.1002/jdn.10003. Epub 2020 Jan 26. Int J Dev Neurosci. 2020. PMID: 31909500 Free PMC article. Review.
This review summarizes our current understanding of the pathogenic cell- and tissue-specific roles of lipid species in the context of experimental therapeutic strategies and provides an overview of critical historical developments, therapeutic trials and the advent …
This review summarizes our current understanding of the pathogenic cell- and tissue-specific roles of lipid species in the context of experi …
Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient.
Wang CX. Wang CX. Paediatr Drugs. 2021 May;23(3):213-221. doi: 10.1007/s40272-021-00441-7. Epub 2021 Apr 8. Paediatr Drugs. 2021. PMID: 33830467 Free PMC article. Review.
Acute treatment modalities include high-dose intravenous corticosteroids, therapeutic plasma exchange, and intravenous immunoglobulin. Long-term outcomes for ADEM are generally favorable, but some children have significant morbidity related to the severity of acute illness …
Acute treatment modalities include high-dose intravenous corticosteroids, therapeutic plasma exchange, and intravenous immunoglobulin …
Anti-MAG neuropathy: From biology to clinical management.
Steck AJ. Steck AJ. J Neuroimmunol. 2021 Dec 15;361:577725. doi: 10.1016/j.jneuroim.2021.577725. Epub 2021 Sep 28. J Neuroimmunol. 2021. PMID: 34610502 Free article. Review.
The acquired chronic demyelinating neuropathies include a growing number of disease entities that have characteristic, often overlapping, clinical presentations, mediated by distinct immune mechanisms, and responding to different therapies. After the discovery in the early …
The acquired chronic demyelinating neuropathies include a growing number of disease entities that have characteristic, often overlapping, cl …
An update on the diagnosis and treatment of adrenoleukodystrophy.
Gujral J, Sethuram S. Gujral J, et al. Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):44-51. doi: 10.1097/MED.0000000000000782. Epub 2022 Nov 14. Curr Opin Endocrinol Diabetes Obes. 2023. PMID: 36373727 Review.
There remains a significant knowledge gap in our understanding and treatment of this disease. Novel therapies such as gene therapy and gene editing have shown promising results in animal models and are exciting potential treatment options for the future.Recently, th …
There remains a significant knowledge gap in our understanding and treatment of this disease. Novel therapies such as gene therapy …
Cannabinoids for the treatment of dementia.
Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak L. Bosnjak Kuharic D, et al. Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2. Cochrane Database Syst Rev. 2021. PMID: 34532852 Free PMC article. Review.
945 results